Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
--------
Question: Luke Miels, who joined GSK in September 2017 after a contract dispute with his former employer AstraZeneca, said picking the most promising projects and developing them quickly now takes precedence over spreading the risk of failure. “In the past, 10 programs were chosen, a budget for eight was allocated. Usually what happened was that time was the trade off that was made,” he said in an interview. “Now what we do is we pick five or six programs, and concentrate investment there.”   GSK, like rivals, was in the habit of testing new drugs first on patients who had run out of other treatment options. If successful, it would try patients at an earlier stage of their disease, replacing older, established treatments. In today’s market, where rivals in the United States and China catch up fast if a new class of drug shows promise, GSK has to run costly drug tests on humans in several settings at the same time, even if it means dropping other drug candidates. “Rather than do things sequentially, you do them in parallel, or as close to parallel as possible,” Miels said. GSK, which is battling to return to profit growth, has taken this approach for instance with an experimental drug that for now goes by the code name of GSK’916 against multiple myeloma, a common and incurable type of blood cancer. Likewise, GSK doubled down on its quest to bring a drug known as GSK’165 to market as a rheumatoid arthritis treatment, even after initial results in a mid-stage drug trial did not show a clear enough reading. “This drug has very interesting effects on pain. That could potentially reduce the use of opioids and pain meds,” Miels said. More trials will be run to make the pain argument more clearly, he added. GSK expects a decline of 5%-9% in adjusted earnings per share this year, excluding exchange rate moves, as it suffers from generic competition to its inhalable lung drug Advair and pressure from rival Gilead in HIV treatments. Miels said a tougher stance on drug prices by U.S. lawmakers and medical insurers was one of the reasons for the need for speed in bringing drugs to market - to try to remain ahead of competitors for as long as possible. At the same time, rapid growth in the Chinese market was spurring a more sophisticated healthcare system there, with local biotech groups quick to catch up with Western pioneers in drug development, producing similar drugs for their home market.

Answer: GSK pharma head flags need for speed in high-pressure drug market.


Question: Alexis Shapiro suffered damage to her pituitary gland, which helps regulate weight, as a result of the brain disease. She has gained about 140 pounds (63.5 kgs) in less than two years because of the problem, her mother said. Her extreme excess of body fat is clinically defined as morbid obesity. “It has been heartbreaking for her and for us. She cannot do the things she used to love,” Jennifer Shapiro, her mother, said on the fundraising site GoFundMe. The mother said she is seeking about $50,000 for life-saving surgery to reduce the size of her daughter’s stomach because the family’s insurance company will not pay for the procedure unless the patient is at least 18 or has achieved full bone growth. Dr. Thomas Inge, a specialist in pediatric obesity at the Cincinnati Children’s Hospital Medical Center, told NBC News that Alexis could receive the surgery at the hospital where he works within six weeks now that the funding appears to be in place. “Alexis will be seen this week in Cincinnati, and the preparations for surgery will be made at that time,” Inge told Reuters by email.

Answer: Donors pitch in to pay for surgery for extremely obese Texas girl.


Question: Why the government is not ordering testing at the nation’s more than 15,000 nursing homes was unclear. Nor was it clear why it is being recommended now, more than two months after the nation’s first major outbreak at a nursing home outside of Seattle that eventually killed 45 people. Vice President Mike Pence, who leads the White House coronavirus task force, told governors on a video conference call that it’s the federal government’s strong recommendation that such testing be done. “We really believe that all 1 million nursing home residents need to be tested within next two weeks as well as the staff,” added Dr. Deborah Birx, the task force coordinator, according to a recording of the call obtained by The Associated Press. President Trump has repeatedly said there have been plenty of testing kits and has shifted blame to governors for reacting too slowly on testing, a charge he repeated in a Rose Garden news conference later Monday. “Frankly, some of the governors were very lax with respect to nursing homes. It was obvious right from the beginning,” Trump said, referring to the Washington state outbreak. Asked why testing was recommended, not ordered, Trump said: “I would certainly consider that. I will mandate it if you’d like.” More than 27,000 residents and staff have died from outbreaks of the virus at the nation’s nursing homes and long-term care facilities, according to an AP tally based on state health departments and media reports. That is about a third of all 80,000 deaths in the U.S. that have been attributed to the virus. Nursing home operators have said the lack of testing kits has left them nearly powerless to stop the virus from entering their facilities because they haven’t been able to identity silent spreaders not showing symptoms. The American Health Care Association, the main nursing home trade group, welcomed the new testing recommendation but said the federal government needed to do more to make that possible, including allocating billions of additional dollars to the effort. Charlene Harrington, a professor emeritus of nursing at the University of California, San Francisco, said nursing homes should have been prioritized from the start given their vulnerable populations and questioned why the testing recommendation is only happening now. “We’re two months into it,” she said. “If they had done that to begin with, we would’ve picked up cases early and we wouldn’t have so many deaths.” Representatives for the federal Centers for Medicare & Medicaid Services did not immediately respond when asked why the agency wasn’t making testing a requirement. In mid-March, it asked homes to cease group gatherings and visitations, and to screen staff with such measures as temperature checks. A senior administration official said taking a tougher stand is still an option. “If the states aren’t able to come back with plans quickly to do it, then there’s a good chance we will order them to do that, but we believe that right now there are plenty of tests out there,” the official said on condition of anonymity because he lacked authorization to speak to the media. West Virginia and Texas have already mandated testing for all nursing home residents and staff. And just Sunday, New York, the nation’s leader in nursing home deaths, began requiring all staff to be tested twice a week. Ohio Republican Gov. Mike DeWine said his state was ramping up testing but cast doubt on the feasibility of doing that for everyone in every home. “I don’t know that that’s going to get done,” said DeWine, whose state has reported nearly 500 deaths in long-term care facilities in three weeks. He added, “There’s frankly a lot of people in the medical field who would argue that the testing of everybody in that nursing home might not be the best protocol.” Pence led the White House’s weekly call with governors from an isolated room after his press secretary tested positive Friday. Three of the country’s top health care officials, including infection disease expert Dr. Anthony Fauci, are quarantining themselves on fears they have been exposed to the virus, too. ___ Condon reported from New York. Candice Choi and Randy Herschaft in New York, Darlene Superville in Washington and Andrew Welsh-Huggins in Columbus, Ohio, contributed to this report.

Answer:
White House recommends tests for all nursing home residents.